AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) to Present at the Canaccord Genuity 32nd Annual Growth Conference

Published: Aug 09, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Canaccord Genuity 32nd Annual Growth Conference on Thursday, August 16, 2012 at 10:00 a.m. (ET) in Boston.

Back to news